American Contact Dermatitis Society (ACDS)

Message from the President

Dear ACDS Member,

As we head into the spring season, let us hope that we continue to go in the right direction with lower COVID cases, with the lessening of restrictions and the opening of businesses. We were fortunate to host the ACDS 33rd Annual Meeting in person on Thursday, March 24 in Boston. It was great seeing all those that ventured to Boston to attend our first live event since the Annual Meeting in 2019 in Washington, D.C.

We had 143 people join us in person, with an additional 165 people registered to access on-demand content virtually. Access to the on-demand content continues to be available through June 24, and offers up to 8.50 AMA PRA Category 1 CreditsTM. If you have not yet registered, you can do so by clicking here. Please also extend a huge congratulations to all of our award winners associated with the Annual Meeting as listed below.

We look forward to seeing more of you in attendance next year for the ACDS 34th Annual Meeting, March 16, 2023 in New Orleans. In addition, we are working hard in bringing the ACDS Fall Meeting back in 2023 with an exciting new destination - Park City, UT.  Watch for more information for both of these exciting events!

Thank you to Outgoing Board Members and Welcome to New Members!

I want to give a heartfelt thank you to the following board members: Drs. Sarah Chisolm, Sara Hylwa and Jiade "Jeff" Yu. Your leadership and service over the past three years has been much appreciated. We look forward to having Drs. Katherine Brown, Salma de la Feld and Aida Lugo-Somolinos on board for the next three years. For a complete list of the ACDS Board of Directors, please click here.

It is my hope that you, our members, have had every opportunity to stay healthy and happy this year.

If you have member news or information you would like highlighted in a future ACDS Newsletter, please email it to


Douglas L. Powell, MD

Facebook: @ACDSDermatitis @DermatitisJournal
Instagram: ACDS_Dermatitis
Twitter: @ACDS_Dermatitis @dermatitisJrnl

Inside this Issue


ACDS 2022 Leadership Updates

We are excited to announce the results of the 2022 ACDS Board of Directors election. Congratulations to the below board members, who took their positions effective March 25, 2022. Please join us in congratulating them on this great honor.

2022 Board of Directors

Katherine Brown, MD

Radnor, PA

Salma de la Feld, MD

Atlanta, GA

Aida Lugo-Somolinos, MD

Chapel Hill, NC

Thank you to the following for their leadership over the past few years. We appreciate your service!

Sarah Chisolm, MD

Atlanta, GA

Sara Hylwa, MD

Minneapolis, MN

Jiade "Jeff" Yu, MD

Boston, MA

For a complete list of the ACDS Board of Directors, please click here.

Back to the Top

Annual Meeting Highlights

The 33rd Annual Meeting of the American Contact Dermatitis Society (ACDS) was held on March 24 in Boston and featured outstanding speakers, making for a memorable meeting. The planning committee included Chair Dr. Ari Goldminz along with members Drs. Nicole Burkemper, Matthew Hall, Clifford Bassett, Alex Flamm, Salma de la Feld, Kari Martin, Golara Honari and Tony Gaspari.

The meeting began with Dr. Jenny Murase speaking during the Regeneron and Sanofi Genzyme sponsored breakfast session on the topic of underlying inflammation and visible burden in atopic dermatitis. Our ACDS President, Dr. Doug Powell, then gave the opening remarks, introduced the new ACDS Peer Mentorship Program, held a moment of silence to recognize the losses of Cindy Froehlich and Dave Severson, and awarded Presidential Citations for exemplary service to the society. Next, Dr. Ari Goldminz, the meeting chair, gave a warm welcome to the attendees and introduced Dr. Don Belsito who announced aluminum as the 2022 ACDS Allergen of the Year.

Over the course of the meeting, various topics in the fields of contact, occupational and atopic dermatitis were covered. The ten Fisher presenters discussed topics from patch testing to topical corticosteroids, to effects of systemic corticosteroids on patch testing results, patch testing-induced anaphylaxis and contact urticaria, eyebrow and eyelash aesthetics, metal allergy and others.

The second half of the morning was dedicated to lectures in the General Session and included a talk on "High Value Dermatitis Care" by Dr. Susan Nedorost, the impact of the Covid-19 pandemic on adults with atopic dermatitis, occupational hand eczema and patch testing results among White, Black, Hispanic and Asian children, among other topics. The Track 2 - Basics of Patch Testing lecture series was pre-recorded and is available on-demand as part of our hybrid approach to the 2022 Annual Meeting.

During the lunch session, sponsored by Dormer/Chemotechnique, Dr. Powell convened the ACDS Annual Business Meeting, acknowledging outgoing board members, recognizing current board members and welcoming new board members. He announced the Dave Severson CAMP internship and presented the Howard Maibach Travel Award to Dr. Eimear Gilhooley from Ireland. Dr. Powell then thanked our top sponsors, including Platinum Sponsors Dormer Laboratories, Inc./Chemotechnique Diagnostics and Regeneron and Sanofi Genzyme; Gold Sponsor Pharmaceutical Specialties; and Silver Sponsor AbbVie. Next, Dr. Kal Watsky provided the ACDS Secretary Treasurer's report and Dr. Tony Gaspari, Dermatitis Editor-in-Chief, gave a Journal update.

Lunch was followed by the Alexander Fisher Lecturer, Dr. Jacob Thyssen, who shared insights through his observations on allergic contact dermatitis over the years. He took us on his fascinating journey to answer various clinical and scientific questions and challenges related to metal allergies and others.

This was followed by the Hot Topics session. Dr. Sarah Chisolm spoke about Advances in Pruritus, covering the latest on mechanisms of itch and treatment options. Next, Dr. Warshaw chronicled contact dermatitis pearls from the masters that endure through uncommon, precious texts. Dr. Esther Freeman delivered a thought-provoking and timely talk on cutaneous reactions to Covid-19 vaccines. Dr. Sandy Skotnicki spoke about approaches for personal care products in the setting of challenging allergens, covering key clinical pearls. Dr. Cory Dunnick discussed the role of telemedicine in contact dermatitis, an area of growing interest in our modern age. Dr. Andrew Alexis presented insights on the important topic of dermatitis and patch testing in skin of color. The Hot Topics session concluded with an exciting panel discussion of practice set up and management, led by Drs. Amber Atwater, Andrew Scheman and Alina Goldenberg.

Dr. Katherine Brown then presented the Fisher Resident and Poster awards. Congratulations to all our winners who are listed below.

The meeting concluded with the Contact Allergen Bee, moderated by Drs. Nicole Burkemper and Jeff Yu; and the cocktail reception.

As a reminder, if you were unable to attend the meeting in person, all Annual Meeting presentations are available online through June 24th. You may register for access here. We look forward to seeing everyone next year for the 34th Annual Meeting, which will take place March 16, 2023, in New Orleans.

Submitted by:
Ari Goldminz, MD
33rd Annual Meeting Committee Chair

Back to the Top

On-Demand Access Now Available!

As a reminder, all content from the ACDS 33rd Annual Meeting is available for viewing on-demand through June 24, 2022. This includes the following educational lectures and poster presentations:

  • Alexander Fisher Lecture
  • Fisher Presentations
  • Basics of Patch Testing
  • General Session Presentations
  • Hot Topics

Back to the Top

If you weren't able to join us in Boston, all content from the ACDS 33rd Annual Meeting is available for viewing on-demand through June 24, 2022. This includes all the above educational lectures and poster presentations. CME is available.

Back to the Top

Complete the Surveys!

We encourage all attendees to provide feedback by completing the individual session surveys found associated with each session's on-demand content.

Have an idea that you would like to see presented at the next Annual Meeting? Be sure to share your input by emailing us at or by completing the general overall annual meeting survey.

Thank you for completing these surveys, which will help us make improvements to our future events.

Back to the Top

Congratulations to the Below Award Recipients!

2022 Alexander A. Fisher Resident Award

The Alexander A. Fisher Resident Award is presented to the best oral presentation by a resident or medical student at the Scientific Session of the ACDS Annual Meeting.

  • Gold - Michelle Xiong, BS - Analysis of Formaldehyde Content in Eyelash Glues
  • Silver - Christina Murphy, BA - Emerging Allergens in Eyebrow and Eyelash Aesthetics
  • Bronze - Joyce Chen, BS - Patch Testing to Topical Corticosteroids: Do Corticosteroid Classes Exist? A Retrospective Analysis of 5,637 Patients and 18 Corticosteroids Over 10 Years at Mayo Clinic

2022 Fran Storrs Poster Award

The Fran Storrs Poster Award is presented to the top three research/review posters at the Scientific Session of the ACDS Annual Meeting.

  • Gold - Eimear Gilhooley, MD - Piloting Photographic Photonic Patch Testing
  • Silver - Maria Antonieta R. Scherrer, MD - Dermatoscopic Aspects of Patch Test Readings
  • Bronze - Sara Abdel Azim, MS - Allergic Contact Dermatitis to Cannabis and Related Essential Oils

2022 Howard I. Maibach Travel Award

The Howard I. Maibach Travel Award provides travel grants to the American Contact Dermatitis Society's Annual Meeting for the presentation of work (either an oral presentation or poster presentation) by investigators outside of the U.S. and Canada.

  • Eimear Gilhooley, MD (Ireland)

2022 Diversity, Equity and Inclusion Travel Award History

The Diversity, Equity and Inclusion Travel Award provides travel grants to the American Contact Dermatitis Society's Annual Meeting for the presentation of work (either an oral presentation or poster presentation) which focuses on diversity, equity, inclusion, or healthcare disparities within dermatitis.

  • Katherine Young, BS, MEng - Comparison of Patch Testing Results Among White, Black, Hispanic, and Asian Children

2022 Diversity, Equity, Inclusion and Healthcare Disparities Poster Award

In recognition of a new initiative surrounding diversity, equity and inclusion, The American Contact Dermatitis Society is pleased to announce the availability of the new DEI Poster Award. This award will recognize work focused around diversity, equity, inclusion and health disparities within dermatitis.

  • Michelle Xiong, BS - Allergenic Ingredients in Sunscreens Marketed for Skin of Color

2022 Contact Allergen Bee Winners

All ACDS Annual Meeting resident attendees had an opportunity to participate in the popular Contact Allergen Bee sponsored by the ACDS Dermatitis Journal. Congrats to our winners!

  • Grand Prize Winner - Wei-Che Ko, MD
  • Runner Up - Kelly Scarberry, MD

Back to the Top

ACDS wishes to thank the following sponsors for their support of the ACDS 33rd Annual Meeting!





Back to the Top

A New Feature For Dermatitis

The Dermatitis editorial office is pleased to announce the addition of a new publication category for our journal, entitled: “Images in Dermatitis”. This new publication category will be in addition to our existing categories of studies, reviews, editorials, abstracts, research letters and pearls & zebras.

Dermatology and especially the forensic art of diagnosing contact dermatitis is a “visual specialty”. We all recognize the central importance of the clinical examination to dermatologic diagnosis. The appearance, the morphology, the shape and distribution of lesions—these features leading to the diagnosis of contact dermatitis as well as other dermatologic diseases. The critical role of the physical examination, provides evidence to make a diagnosis visually, is part of the art of the study of contact dermatitis and related conditions and is shared by few other medical specialties.

This new publication category will be available in print and online issues of Dermatitis. The structure of “Images in Dermatitis” is similar to that of research letters or pearls & zebras (see below). This new category differs in that the image (or images) will be the centerpiece of the publication. The images can be a novel or an unusual presentation or a classic presentation of contact dermatitis, patch test reactions, atopic dermatitis, occupational dermatitis or drug-induced dermatitis. Similar to all submissions to the journal, manuscripts will undergo peer-review.

The purpose of this new publication category is to build an image database on our website, which can serve as an additional educational resource for our members. Manuscripts published as “Images in Dermatitis” can be cited by authors submitting articles to Dermatitis as well as other journals. Thus, “Images in Dermatitis” can contribute in a positive way to the impact factor of our Journal. It is also a celebration of the joy of the visual nature of our specialty. Instructions for this type of submission are summarized below and are also posted on our Journal’s website.

Instructions for Submitting a Manuscript

This feature is intended to provide a high-quality visual image of interesting and unique dermatological observations related to Contact, Occupational, Atopic and Drug-Induced dermatitis. These include clinical images of skin diseases (i.e., photographs, photomicrographs, and other images) that enhance the understanding of cutaneous pathophysiology and improve clinicians' ability to diagnose and treat skin disorders.

Up to a 500-word description of the clinical issue, the patient's presentation and findings, and the image should be included. There should be no more than 2 images (figures), 5 references, and no more than 3 authors. Online supplementary material is not allowed.

For Dermatitis, the images should address one or more of the four major areas of focus of our Journal (Contact, Occupational, Atopic and Drug). The Images will be published in the print version of Dermatitis, and on the Journal website as part of an image gallery.

If the patient(s) described in these manuscripts is identifiable, a Patient Permission form must be completed and signed by the patient(s) and submitted with the manuscript. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable.

We look forward to receiving your submissions for this new category of publication in Dermatitis.

Top Ten Scoring Altmetric Articles in Dermatitis from 2021

Our Dermatitis publisher’s annual report includes a measure of world-wide attention which our published articles receive from the preceding year. Articles receive an “Altmetric Score”, which represents a cumulative score that includes both academic (scholarly) as well as non-academic citations (social media mentions-such as newspapers, blogs, tweets). The higher the Altmetric score, the more attention the article is receiving. Altmetric scores of 15 or higher are considered to be strong “Attention-Getters”, which is great news for the Journal.

Here are the “Top 10” Dermatitis articles for 2021, ranked by their Altmetric scores (publication dates and Altmetric scores in parentheses):

  1. Atopic Dermatitis Is Associated With Multiple Behavioral Problems in US Children and Adolescents (publication date: 4/9/2021; Altmetric score: 17)
  2. Autoimmune Progesterone Dermatitis (publication date: 8/16/2021; Altmetric score: 15)
  3. North American Contact Dermatitis Group Patch Test Results: 2017–2018 (publication date: 3/1/2021; Altmetric score: 12)
  4. Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care Workers (publication date: 1/1/2021; Altmetric score: 10)
  5. Reducing Discomfort and Irritation Related to Surgical Loop Masks in the Era of COVID-19: A Quality Improvement Initiative (publication date: 3/3/2021; Altmetric score: 10)
  6. Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy (publication date: 8/16/2021; Altmetric score: 10)
  7. The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis—A Nested Case-Control Study (publication date: 6/16/2021; Altmetric score: 10)
  8. Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate–Induced Dermatitis Model in Mice (publication date: 3/4/2021; Altmetric score: 9)
  9. Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States (publication date: 9/27/2021 Altmetric score: 7)
  10. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review (publication date: 4/12/2021; Altmetric score: 7)

It is noteworthy that all of the Dermatitis areas of interest (Contact, Occupational, Atopic and Drug) were represented in this “Attention-Getter” list, with Atopic dermatitis-related articles leading the way (three of the top 10 articles).

Congratulations to the authors of these articles!

Anthony A. Gaspari, MD
Dermatitis Editor-in-Chief

Back to the Top

ACDS Set to Achieve Full Delegate Status at June, 2022 AMA Meeting

ACDS is expected to become a member society of the American Medical Association (AMA) House of Delegates at its June 2022 meeting in Chicago. This will be the first live AMA meeting since 2019.

As a full voting member society, the ACDS will have a vote on all AMA policy issues and elections. ACDS will also be eligible to appoint an Alternate Delegate, as well as an advisor to the AMA's RVU Update Committee (RUC) and the Current Procedure Terminology (CPT) Committee in the future.

This meeting has particular significance to dermatology as Jack Resneck, Jr., MD, FAAD, a dermatologist and Vice-Chair at UCSF Department of Dermatology, will be inducted as AMA President.

Stay tuned for more information after the meeting on the latest policy adopted at the AMA Annual 2022.

Bruce A. Brod, MD, MHCI, FAAD
ACDS Representative to the AMA

Alexandra Flamm, MD, FAAD
Chair, ACDS Health Policy Committee

Back to the Top

Please join us in congratulating Bruce Brod, MD MHCI on being a newly elected Board Member of the American Academy of Dermatology. Dr. Brod is a clinical professor of dermatology at the University of Pennsylvania Perelman School of Medicine. He currently serves as chair of the AADA's Council on Government Affairs and Healthy Policy. He previously served as president of the Pennsylvania Academy of Dermatology and Dermatologic Surgery, Philadelphia Dermatological Society and the American Contact Dermatitis Society.

Back to the Top

Save the Date for the ACDS 34th Annual Meeting!

Back to the Top

Follow ACDS on

Back to the Top


ACDS®  |  555 East Wells Street, Suite 1100  |  Milwaukee, WI 53202
Tel: (414) 276-6445  |  Fax: (414) 276-3349  |  Email:

Follow us


Support ACDS® with AmazonSmile
ACDS: Amazon Smile

If you do not wish to be included in our mailing list, please forward this message to